Apontis Pharma AG - Laporan Laba Rugi (TTM)

Apontis Pharma AG
DE ˙ XTRA ˙ DE000A3CMGM5
€ 10.80 ↑0.25 (2.37%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Apontis Pharma AG menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 39 42 46 48 51 54 56 56 56 51 46 42 37 39 41 45 48 50 52
Change (%) 8.09 7.48 6.14 5.78 4.54 4.34 -0.09 -0.09 -8.61 -9.43 -9.93 -11.03 4.96 4.73 9.64 8.79 3.41 3.30
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 14 15 16 17 17 19 20 20 21 19 17 15 14 15 16 18 21 21 22
Change (%) 7.67 7.13 3.05 2.96 6.83 6.39 2.43 2.38 -9.51 -10.51 -8.92 -9.80 6.98 6.53 16.05 13.83 2.15 2.11
% of Revenue 36.23 36.09 35.97 34.92 33.99 34.73 35.42 36.31 37.21 36.84 36.40 36.81 37.32 38.03 38.69 40.95 42.84 42.32 41.84
Gross Operating Profit 25 27 29 31 34 35 36 36 35 32 29 26 23 24 25 26 28 29 30
Change (%) 8.32 7.68 7.87 7.30 3.36 3.25 -1.48 -1.50 -8.08 -8.79 -10.51 -11.74 3.76 3.62 5.60 5.30 4.35 4.17
% of Revenue 63.77 63.91 64.03 65.08 66.01 65.27 64.58 63.69 62.79 63.16 63.60 63.19 62.68 61.97 61.31 59.05 57.16 57.68 58.16
SG&A 18 20 22 21 20 18 17 19 20 21 21 21 21 19 18 16 15 15 16
Change (%) 9.73 8.86 -4.45 -4.66 -6.39 -6.83 8.64 7.95 2.93 2.85 -0.94 -0.95 -7.85 -8.51 -7.59 -8.21 2.56 2.50
% of Revenue 46.21 46.91 47.52 42.78 38.55 34.52 30.83 33.52 36.22 40.80 46.33 50.95 56.72 49.80 43.50 36.67 30.94 30.68 30.45
R&D
Change (%)
% of Revenue
OpEx 40 44 48 47 47 46 45 49 52 51 50 48 47 45 44 46 47 49 51
Change (%) 10.05 9.13 -1.15 -1.16 -1.74 -1.77 7.40 6.89 -2.18 -2.23 -3.10 -3.20 -2.42 -2.48 3.30 3.19 3.71 3.58
% of Revenue 101.83 103.68 105.27 98.04 91.60 86.10 81.05 87.14 93.23 99.79 107.72 115.90 126.09 117.22 109.15 102.83 97.53 97.82 98.08
Operating Income -1 -2 -2 1 4 7 11 7 4 0 -4 -7 -10 -7 -4 -1 1 1 1
Change (%) 116.96 53.91 -139.52 353.06 73.02 42.20 -32.16 -47.41 -97.22 -3,491.83 85.33 46.04 -30.73 -44.36 -66.07 -194.73 -8.48 -9.27
% of Revenue -1.83 -3.68 -5.27 1.96 8.40 13.90 18.95 12.86 6.77 0.21 -7.72 -15.90 -26.09 -17.22 -9.15 -2.83 2.47 2.18 1.92
Interest Expense -1 -1 -1 -1 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
Change (%) -1.17 -1.19 -25.76 -40.12 -50.81 100.00 -0.00 -4.83 219.64 68.72 -0.00 6.62 -58.62
% of Revenue -2.05 -1.88 -1.73 -1.21 -0.68 -0.32 -0.02 -0.05 -0.05 -0.05 -0.16 -0.27 -0.24 -0.24 -0.09
Net Income -1 -1 -1 -1 -1 2 4 3 3 -0 -3 -7 -11 -9 -7 -3 1 1 1
Change (%) 10.24 9.29 -23.86 -31.33 -305.15 148.74 -14.65 -17.16 -109.21 1,186.01 127.50 56.04 -18.69 -22.98 -55.32 -123.83 -6.57 -7.03
% of Revenue -3.01 -3.07 -3.13 -2.24 -1.46 2.86 6.81 5.82 4.82 -0.49 -6.90 -17.44 -30.58 -23.69 -17.42 -7.10 1.55 1.40 1.26

Source: Capital IQ

Other Listings
GB:APPHD
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista